Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival. (Q47826998)
Jump to navigation
Jump to search
scientific article published on 30 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival. |
scientific article published on 30 April 2012 |
Statements
Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival (English)
Thierry Facon
Philippe Moreau
Margaret Macro
Anne-Marie Stoppa
Mourad Tiab
Gerald Marit
Marc Wetterwald
Laurent Voillat
Michel Attal
Brigitte Pegourie
Eric Voog
Claire Mathiot
Anne Banos
Catherine Traulle
Florence Magrangeas
Stephane Minvielle
Denis Caillot
Cyrille Hulin
Jerome Jaubert